Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Dreno

Showing results (161-170 of 213) with videos related to

Pageof 22
Sort By:
Archives of Dermatology|June 19, 2008
Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndromeGaëlle Quereux, Sonia Marques, Jean-Michel Nguyen, et al.
Medicine|March 11, 2005
Brain magnetic resonance imaging in patients with Cowden syndromeCatherine Lok, Valérie Viseux, Marie Françoise Avril, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 7, 2020
Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell LymphomaPierluigi Porcu, Stacie Hudgens, Steven Horwitz, et al.
Plos One|March 4, 2014
TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trialBrigitte Dreno, Mirjana Urosevic-Maiwald, Youn Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2016
Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with IpilimumabAlexander Martens, Kilian Wistuba-Hamprecht, Jianda Yuan, et al.
Clinical and Experimental Dermatology|June 17, 2026
Prevalence of melasma, quality-of-life impact and social stigmatizationAndrew F Alexis, Brigitte Dreno, Wei Liu, et al.
Clinical and Experimental Dermatology|August 12, 2025
Stigmatization in patients with pigmentation disorders: the ISPOT studyThierry Passeron, Wei Liu, Akimichi Morita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic MelanomaWim H J Kruit, Stefan Suciu, Brigitte Dreno, et al.
European Journal of Dermatology : EJD|March 1, 2023
Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel databaseJean-Matthieu L'Orphelin, Sara Le Naour, Stephane Dalle, et al.
Oncoimmunology|April 22, 2020
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trialJulie Charles, Laurence Chaperot, Dalil Hannani, et al.
Pageof 22

Showing results (161-170 of 213) with videos related to

Sort By:
Pageof 22
Archives of Dermatology|June 19, 2008
Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndromeGaëlle Quereux, Sonia Marques, Jean-Michel Nguyen, et al.
Medicine|March 11, 2005
Brain magnetic resonance imaging in patients with Cowden syndromeCatherine Lok, Valérie Viseux, Marie Françoise Avril, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 7, 2020
Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell LymphomaPierluigi Porcu, Stacie Hudgens, Steven Horwitz, et al.
Plos One|March 4, 2014
TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trialBrigitte Dreno, Mirjana Urosevic-Maiwald, Youn Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2016
Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with IpilimumabAlexander Martens, Kilian Wistuba-Hamprecht, Jianda Yuan, et al.
Clinical and Experimental Dermatology|June 17, 2026
Prevalence of melasma, quality-of-life impact and social stigmatizationAndrew F Alexis, Brigitte Dreno, Wei Liu, et al.
Clinical and Experimental Dermatology|August 12, 2025
Stigmatization in patients with pigmentation disorders: the ISPOT studyThierry Passeron, Wei Liu, Akimichi Morita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic MelanomaWim H J Kruit, Stefan Suciu, Brigitte Dreno, et al.
European Journal of Dermatology : EJD|March 1, 2023
Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel databaseJean-Matthieu L'Orphelin, Sara Le Naour, Stephane Dalle, et al.
Oncoimmunology|April 22, 2020
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trialJulie Charles, Laurence Chaperot, Dalil Hannani, et al.
Pageof 22